Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Oct 19, 2020 10:19am
142 Views
Post# 31738458

RE:RE:Virtual presentations hosted by JTC

RE:RE:Virtual presentations hosted by JTCPerhaps your suggestion will be taken.<br /> <br /> If they are to present, hopefully they skip quickly on the generalities and hit the nuts and bolts on the&nbsp;3 trials<br /> <br /> 1) BG pill as cholesterol reducer, study already under way<br /> 2) Covid PGX Y-BG, details for human phase 1/2 studies by year end if animal studies are good<br /> 3) AV as an&nbsp; anti-inflammatory, initiation of bioavailability study with pharma grade pill by year end<br /> <br /> and any updates on the PGX - Y-BG plant<br /> <br /> Finally the stock is being hit on the ask side today with some half decent volume at the open.<br />
<< Previous
Bullboard Posts
Next >>